4th ACTC | Advances in Circulating Tumor Cells | Liquid Biopsy: Latest Advances and Future Challenges

Confirmed Speakers

CONFIRMED SPEAKERS

Catherine Alix Panabieres

Catherine Alix-Panabières.  PhD, Laboratoire Cellules CirculantesRaresHumaines – LCCRH, Institut de Recherche en Biothérapie – IRB , Hôpital Saint-Eloi – CHRU Montpellier, France.

Emmanouel Antonarakis

Emmanuel Antonarakis.  MD, Associate Professor of Oncology and Urology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, USA.

Alberto Bardelli

Alberto Bardelli.  PhD, Professor, Dept of Oncology, University of Torino – Candiolo Cancer Institute, President, European Association for Cancer Research, Torino, Italy.

Carlos Caldas

Carlos Caldas.  Professor of Cancer Medicine, University of Cambridge, and Head, Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, Cambridge, UK.

George Adrian Calin

George Adrian Calin.  MD PhD, Professor,Department of Experimental Therapeutics, Division of Cancer Medicine, Co-Director, The RNA Interference and non-coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Massimo Cristofanilli

Massimo Cristofanilli.  MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Department of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center Feinberg School of Medicine, Chicago, IL, USA.

Richard J. Cote

Richard J. Cote.  M.D., FCRPath, FCAP, Professor and Incoming Chair, Department of Pathology and Immunology, Pathologist-in-Chief, barnes-Jewish hospital, Washington University in St. Louis, St. Louis, USA.

Caroline Dive

Caroline Dive. PhD, Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology,  The University of Manchester, UK.

Francoise Farace

Francoise Farace. PhD, Gustave Roussy, Université Paris-Saclay, “Circulating Tumor Cells” Translational Platform, CNRS UMS3655 – INSERM US23 AMMICA, F-94805, VILLEJUIF, France.

Dave Hoon

Dave Hoon. PhD, Director, Department of Molecular Oncology, John Wayne Cancer Institute, Santa Monica, CA, USA.

Michael Ignatiadis

Michael Ignatiadis. MD PhD, Assistant Professor, Jules Bordet Institute Brussels, Belgium.

Wolfgang Janni

Wolfgang Janni. MD PhD, Medical Director of the Gynecological University Hospital Ulm, University of Ulm, Germany.

Stefanie S. Jeffrey

Stefanie S. Jeffrey. MD, John and Marva Warnock Professor, Department of Surgery, Chief of Surgical Oncology Research, Stanford University, School of Medicine, Stanford, USA.

Raghu Kalluri

Raghu Kalluri. MD, PhD, Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Yibin Kang

Yibin Kang. PhD, Warner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University, Princeton, New Jersey, USA.

Sabine Kasimir Bauer

Sabine Kasimir Bauer. PhD, Professor, Head of Laboratory, Department of Gynecology and Obstetrics, University Hospital of Essen, Germany.

Gary_Kelloff

Gary Kelloff. M.D., Special Advisor, CIP, DCTD, National Cancer Institute, NIH, USA.

Peter Kuhn

Peter Kuhn. PhD, Dean’s Professor of Biological Sciences and Professor of Medicine, Biomedical Engineering, Aerospace & Mechanical Engineering, Associate Director of The Bridge at USC Los Angeles, CA, USA.

Evi Lianidou

Evi Lianidou. PhD, Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece.

Mike Makrigiorgos

Mike Makrigiorgos. PhD, Professor and Director, Medical Physics and Biophysics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA.

Dario Marchetti

Dario Marchetti. PhD, Director of the Biomarker Research Program at Houston Methodist Research Institute and Professor of Biomarkers Research at Houston Methodist, Houston, TX, USA.

Michael Neumaier. M.D., Professor of Clinical Chemistry, Department of Clinical Chemistry, University Medical Center, Ruprecht-Karls University of Heidelbergh Mannheim Germany, President of the European Society of Laboratory Medicine, Germany.

Klaus Pantel

Klaus Pantel. MD, PhD, Professor, Director, Institute of Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg Eppendorf, Hamburg, Germany.

Nickolas Papadopoulos

Nickolas Papadopoulos. PhD, Professor of Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics and Therapeutics,Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA.

Jean Yves Pierga

Jean Yves Pierga. MD, PhD, Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France.

Amanda Psyrri

Amanda Psyrri. MD, PhD, Assoc. Professor, University of Athens Medical School, Attikon University Hospital, Athens, Greece.

Thomas Schlange

Thomas Schlange. PhD, Senior Biomarker Scientist, Global Biomarker Research, Bayer Pharma, Germany.

Howard Scher

Howard Scher. MD, Medical Oncologist, Co-Chair, Center for Mechanism Based Therapy; Head of the Biomarker Development Initiative; D. Wayne Calloway Chair in Urologic Oncology, Memorial Sloan Kettering Cancer Research, New York, NY, USA.

Michael Speicher

Michael Speicher. Institute of Human Genetics, Medical University of Graz, Austria.
Michael R. Speicher, M.D. is Professor of Human Genetics and Head of the Institute of Human Genetics at the Medical University of Graz in Austria. Dr. Speicher studied computer science at the University of Dortmund (Germany) and graduated with an MD degree from the University of Essen (Germany). He conducted his clinical and scientific training in Human Genetics at the University of Heidelberg (Germany), at Yale University (New Haven, USA), and at the University of Munich (Germany).
For many years Dr. Speicher studied chromosome structure and morphology using various molecular cytogenetic approaches and mechanisms of chromosomal instability. His more recent research is focused on hereditary tumor syndromes, the contribution of germline and somatic genomic variants to cancer, and single cell analysis. Current research projects are directed towards methods for the non-invasive monitoring of cancer evolution by analyses of circulating tumor cells and circulating tumor DNA.

Nikolas Stoecklein

Nikolas Stoecklein. MD, Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany.

Leon Terstappen

Leon Terstappen. PhD, Professor, Faculty of Science and Technology, MIRA Research Institute, Department of Medical Cell Biophysics, University of Twente, the Netherlands.

Jean Paul Thiery

Jean Paul Thiery. PhD, Professor, Research Director CNRS Emeritus CNRS UMR 7057 Matter and Complex Systems, University Paris Denis Diderot, Paris, France.

Rik Thompson

Rik Thompson. PhD, Professor, Associate Director, Faculty of Health, School – Biomedical Sciences,Research – Biomedical Sciences, Queensland University of Technology, Brisbane, Australia.

Thomas Wurdinger

Thomas Würdinger. VU University Medical Center, Amsterdam, The Netherlands.
Thomas Würdinger obtained his PhD in virology and gene therapy at Utrecht University, Utrecht, The Netherlands. After that he moved to Boston, USA to start his postdoc period as a research fellow at Massachusetts General Hospital and Harvard Medical School under the guidance of Prof. dr. X.O. Breakefield and Prof. dr. R. Weissleder. He has a position as professor at VU University Medical Center and Cancer Center Amsterdam, The Netherlands. He is co-founder of thromboDx BV and Exbiome BV.

4th ACTC | Advances in Circulating Tumor Cells | Liquid Biopsy: Latest Advances and Future Challenges